“…First, incomplete data on secondary antibiotic prophylaxis adherence hampered our ability to detect any protective effect of high adherence against negative outcomes, as some studies suggest. 26 , 27 , 28 , 29 Data that were available showed that half of the patients had low adherence to secondary antibiotic prophylaxis, which is consistent with previous studies in sub-Saharan Africa that attribute suboptimal adherence to barriers that include fear of pain or anaphylaxis, limited health-care access, and low awareness of the detrimental consequences of acute rheumatic fever and rheumatic heart disease. 26 Second, our study included a relatively small sample size, which led to broad confidence intervals relating to our incidence rates and HRs and hampered our ability to detect risk factors that might have minor, but still important, effects on mortality.…”